Alimentary Pharmacology and Therapeutics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Letter: all or nothing —placebo effects in a non‐drug clinical trial in IBS
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 105-106, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 8, 2018 Category: Drugs & Pharmacology Authors: P. Enck Source Type: research
Letter: all or nothing —placebo effects in a non‐drug clinical trial in IBS. Authors’ reply
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 106-107, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 8, 2018 Category: Drugs & Pharmacology Authors: D. Schumann
,
H. Cramer Source Type: research
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 107-108, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 8, 2018 Category: Drugs & Pharmacology Authors: E. Marabotto
,
M. Furnari
,
E. G. Giannini
,
V. Savarino
,
E. Savarino Source Type: research
Letter: can the overall gastrointestinal safety of celecoxib be extended to all COX ‐2‐selective agents?
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 1, Page 108-110, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 8, 2018 Category: Drugs & Pharmacology Authors: C. Scarpignato
,
C. Blandizzi Source Type: research
Review article: Asia ‐Pacific consensus recommendations on endoscopic tissue acquisition for biliary strictures
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 7, 2018 Category: Drugs & Pharmacology Authors: B. Sun
,
J. H. Moon
,
Q. Cai
,
R. Rerknimitr
,
S. Ma
,
S. Lakhtakia
,
S. Ryozawa
,
H. Kutsumi
,
I. Yasuda
,
H. Shiomi
,
X. Li
,
W. Li
,
X. Zhang
,
T. Itoi
,
H. ‐P. Wang
,
D. Qian
,
J. Y. Wong Lau
,
Z. Yang
,
M. Ji
,
Source Type: research
Risk of post ‐operative surgical site infections after vedolizumab vs anti‐tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 7, 2018 Category: Drugs & Pharmacology Authors: K. T. Park
,
L. Sceats
,
M. Dehghan
,
A. W. Trickey
,
A. Wren
,
J. J. Wong
,
R. Bensen
,
B. N. Limketkai
,
K. Keyashian
,
C. Kin Source Type: research
Antigenic response to CT ‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 6, 2018 Category: Drugs & Pharmacology Authors: J. Goncalves
,
M. Santos
,
R. Acurcio
,
I. Iria
,
L. Gouveia
,
P. Matos Brito
,
A. Catarina Cunha ‐Santos
,
A. Barbas
,
J. Galvão
,
I. Barbosa
,
F. Aires da Silva
,
A. Alcobia
,
M. Cavaco
,
M. Cardoso
,
J. Delgado Alves
,
Source Type: research
Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population ‐based cohort study
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 5, 2018 Category: Drugs & Pharmacology Authors: J. M. Bae
,
H. H. Lee
,
B. ‐I. Lee
,
K.‐M. Lee
,
S. H. Eun
,
M.‐L. Cho
,
J. S. Kim
,
J. M. Park
,
Y.‐S. Cho
,
I. S. Lee
,
S. W. Kim
,
H. Choi
,
M.‐G. Choi Source Type: research
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium ‐competitive acid blocker, in healthy male subjects
Alimentary Pharmacology&Therapeutics,Volume 48, Issue 2, Page 206-218, July 2018. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 4, 2018 Category: Drugs & Pharmacology Authors: J. Sunwoo
,
J. Oh
,
S. J. Moon
,
S. C. Ji
,
S. H. Lee
,
K. ‐S. Yu
,
H. S. Kim
,
A. Lee
,
I.‐J. Jang Source Type: research
RNA sequencing confirms similarities between PPI ‐responsive oesophageal eosinophilia and eosinophilic oesophagitis
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 4, 2018 Category: Drugs & Pharmacology Authors: K. A. Peterson
,
M. Yoshigi
,
M. W. Hazel
,
D. A. Delker
,
E. Lin
,
C. Krishnamurthy
,
N. Consiglio
,
J. Robson
,
M. Yandell
,
F. Clayton Source Type: research
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 4, 2018 Category: Drugs & Pharmacology Authors: C. Labenz
,
J. S. Baron
,
G. Toenges
,
J. M. Schattenberg
,
M. Nagel
,
M. F. Sprinzl
,
M. Nguyen ‐Tat
,
T. Zimmermann
,
Y. Huber
,
J. U. Marquardt
,
P. R. Galle
,
M.‐A. Wörns Source Type: research
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium‐competitive acid blocker, in healthy male subjects
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 4, 2018 Category: Drugs & Pharmacology Authors: J. Sunwoo
,
J. Oh
,
S. J. Moon
,
S. C. Ji
,
S. H. Lee
,
K. ‐S. Yu
,
H. S. Kim
,
A. Lee
,
I.‐J. Jang Source Type: research
Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 4, 2018 Category: Drugs & Pharmacology Authors: F. Wandrer
,
B. Han
,
S. Liebig
,
J. Schlue
,
M. P. Manns
,
K. Schulze ‐Osthoff
,
H. Bantel Source Type: research
Randomised clinical trial: Tong ‐Xie‐Yao‐Fang granules versus placebo for patients with diarrhoea‐predominant irritable bowel syndrome
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - June 1, 2018 Category: Drugs & Pharmacology Authors: M. Chen
,
T. ‐C. Tang
,
Y. Wang
,
J. Shui
,
X.‐H. Xiao
,
X. Lan
,
P. Yu
,
C. Zhang
,
S.‐H. Wang
,
J. Yao
,
H. Zheng
,
D.‐Q. Huang Source Type: research
Systematic review with meta ‐analysis: recurrence of hepatocellular carcinoma following direct‐acting antiviral therapy
Alimentary Pharmacology&Therapeutics, EarlyView. (Source: Alimentary Pharmacology and Therapeutics)
Source: Alimentary Pharmacology and Therapeutics - May 31, 2018 Category: Drugs & Pharmacology Authors: N. Saraiya
,
A. C. Yopp
,
N. E. Rich
,
M. Odewole
,
N. D. Parikh
,
A. G. Singal Source Type: research